Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Alzheimer's disease (AD) and Parkinson's disease (PD) are distinct neurodegenerative disorders.
• Shared pathological mechanisms are increasingly recognized between AD and PD.
• Amyloid beta (Abeta) in AD and alpha-synuclein in PD are well-studied parallels.

Purpose of the Study:

• To explore emerging parallels between Abeta in AD and neuromelanin (NM) in PD.
• To investigate the shared characteristics and roles of Abeta and NM in neurodegeneration.
• To analyze the dual neuroprotective and neurotoxic functions of Abeta and NM.

Main Methods:

• Comparative analysis of molecular characteristics of Abeta and NM.
• Review of recent literature on Abeta, NM, and their roles in aging and neurodegeneration.
• Examination of Abeta and NM interactions with metals and toxic species.

Main Results:

• Both Abeta and NM accumulate with aging, a key risk factor for AD and PD.
• Abeta and NM share properties that may confer neuroprotection, including metal binding and detoxification.
• Both molecules can activate microglia, contributing to neuroinflammation and neuronal death via factors like TNF-alpha, IL-6, and NO.

Conclusions:

• Abeta and NM display parallel roles in the neurodegenerative processes of AD and PD.
• Understanding these parallels, including their dual protective/toxic effects, can enhance insights into neurodegeneration.
• Further analysis may reveal common therapeutic targets for AD and PD.